Skip to main content

Table 5 Diagnostic accuracy of Microlife WatchBP AFIB in DM patients according to the HbA1c control

From: Targeted screening of atrial fibrillation using automated blood pressure measurement device with atrial fibrillation detection function, in patients with type 2 diabetes mellitus in primary care setting

 

HbA1c < 7%

HbA1c ≥ 7%

Sensitivity (%) (95% CI)

83.3 (62.3–95.6)

71.4 (35–94.6)

Specificity (%) (95% CI)

97.9 (97–98.6)

98.1 (96.9–98.9)

PPV (%) (95% CI)

35.7 (22.4–50.7)

26.3 (10.3–48.3)

NPV (%) (95% CI)

99.8 (99.4–99.9)

99.7 (99.1–1)

Positive LR (95% CI)

38.981(25.446–59.716)

37.092 (18.437–74.62)

Negative LR (95% CI)

0.17 (0.061–0.478)

0.291 (0.09–0.94)